Literature DB >> 29268817

MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis.

Jianli Chen1, Xiaowen Chen2.   

Abstract

Breast cancer remains a public health issue on a global scale. The present study aimed to explore the functional role of MYB proto-oncogene like 2 (MYBL2) in breast cancer, as well as underlying mechanisms. The regulatory relationship between miR-143-3p and MYBL2 was analyzed, and the effects of dysregulation of miR-143-3p and MYBL2 on cell proliferation and apoptosis were investigated. The results showed that MYBL2 and miR-143-3p were inversely expressed in breast cancer tissues and cells: MYBL2 was highly expressed, whereas miR-143-3p was lowly expressed. MYBL2 was confirmed as a target gene of miR-143-3p. Suppression of MYBL2 inhibited proliferation and induced apoptosis of breast cancer cells, which was similar to the effects of overexpression of miR-143-3p. Our findings reveal that MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29268817     DOI: 10.3727/096504017X15135941182107

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  20 in total

1.  Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis.

Authors:  Zheng Chen; Zheng Li; Mohammed Soutto; Weizhi Wang; M Blanca Piazuelo; Shoumin Zhu; Yan Guo; Maria J Maturana; Alejandro H Corvalan; Xi Chen; Zekuan Xu; Wael M El-Rifai
Journal:  Gastroenterology       Date:  2018-11-28       Impact factor: 22.682

2.  Microarray data reveal potential genes that regulate triple-negative breast cancer.

Authors:  Chi Pan; Aihua Cong; Qingtao Ni
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

3.  [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].

Authors:  M Yang; X Zhu; Y Shen; Q He; Y Qin; Y Shao; L Yuan; H Ye
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

4.  Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.

Authors:  Yu-Chao Xiong; Jiao Wang; Yong Cheng; Xin-Yi Zhang; Xiao-Qun Ye
Journal:  Mol Cell Biochem       Date:  2020-03-21       Impact factor: 3.396

5.  microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.

Authors:  Shan Pan; Mengyu Li; Haibo Yu; Zhiguo Xie; Xia Li; Xianlan Duan; Gan Huang; Zhiguang Zhou
Journal:  Acta Diabetol       Date:  2020-08-20       Impact factor: 4.280

6.  Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene.

Authors:  Xingjie Chen; Yalin Lu; Hao Yu; Kangjie Du; Yu Zhang; Yang Nan; Qiang Huang
Journal:  Cell Cycle       Date:  2021-09-29       Impact factor: 5.173

7.  Epigenetic regulation of HOTAIR in advanced chronic myeloid leukemia.

Authors:  Ziye Li; Jianmin Luo
Journal:  Cancer Manag Res       Date:  2018-11-05       Impact factor: 3.989

8.  Integrated Analysis of MicroRNA (miRNA) and mRNA Profiles Reveals Reduced Correlation between MicroRNA and Target Gene in Cancer.

Authors:  Xingsong Li; Xiaokang Yu; Yuting He; Yuhuan Meng; Jinsheng Liang; Lizhen Huang; Hongli Du; Xueping Wang; Wanli Liu
Journal:  Biomed Res Int       Date:  2018-12-06       Impact factor: 3.411

9.  Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma.

Authors:  Hiroki Sanada; Naohiko Seki; Keiko Mizuno; Shunsuke Misono; Akifumi Uchida; Yasutaka Yamada; Shogo Moriya; Naoko Kikkawa; Kentaro Machida; Tomohiro Kumamoto; Takayuki Suetsugu; Hiromasa Inoue
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

10.  Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network.

Authors:  Zhangya Pu; Yuanyuan Zhu; Xiaofang Wang; Yun Zhong; Fang Peng; Yiya Zhang
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.